Speaking Engagement
CBI’S 17TH ANNUAL PHARMACEUTICAL COMPLIANCE CONGRESS: CCO SHOWCASE | Cutting-Edge and Proactive Models Driving Compliance and Transcending Silos Across the Business
Wednesday, August 12 11:40 AM EST to 12:40 PM EST
Virtual Conference
CBI’s annual Pharmaceutical Compliance Congress is the world’s largest event for compliance and legal professionals in the bio/pharma industry. This year, Life Sciences Consulting Group Leader, BJ D’Avella will moderate a panel that show cases cutting-edge and proactive models driving compliance and transcending silos across the business as well as conduct a Q&A session with the Showcase panel participants.
Presentations will include:
Delivery Disruption — Innovative and Dynamic Ways of Communicating to Influence and Inspire a Culture of Compliance
A Culture of Compliance — Leveraging E&C to Motivate the Middle and Further the Frontline
Bringing the Business into Compliance — Leveraging Champions, Town Halls and Rotations to Foster a Compliant Culture
Progressive Insights and Initiatives for CCOs at Emerging and Newly Commercial Companies
Your CIA is Ending — Now What? Best Practices for Transitioning from a CIA to Your Own Modern Risk-Based Compliance Program
Digital Health Initiatives
Moderator:
BJ D’AvellaLeader, Life Sciences Consulting GroupPaul Hastings LLP
Panelists:
Beth LevineSenior Vice President, Associate General Counsel, Chief Compliance OfficerRegeneron
Jill MacalusoCorporate Vice President, North America, Chief Ethics, Compliance and Privacy OfficerNovo Nordisk
Bryant AaronVice President, Chief Compliance Officer, U.S. Country Head, Ethics & ComplianceNovartis Pharmaceuticals Corporation
Tina BeamonVice President, Chief Compliance OfficerKaryopharm Therapeutics, Inc
Joshua MarksVice President, Chief Ethics and Compliance OfficerBoehringer Ingelheim
Daryl KremlChief Compliance Officer, Vice PresidentSAGE Therapeutics
